TY - JOUR
KW - Humans
KW - *Aripiprazole/therapeutic use/adverse effects
KW - Female
KW - Male
KW - Middle Aged
KW - *Antipsychotic Agents/therapeutic use/adverse effects
KW - Adult
KW - *Mental Disorders/drug therapy
KW - Quetiapine Fumarate/therapeutic use/adverse effects
KW - Treatment Outcome
KW - Risperidone/therapeutic use/adverse effects
KW - Aged
KW - Olanzapine/therapeutic use/adverse effects
KW - Hospitalization/statistics & numerical data
AU - A. Richards-Belle
AU - N. Launders
AU - S. Hardoon
AU - A. Richards
AU - K. Man
AU - N. Davies
AU - E. Bramon
AU - J. Hayes
AU - D. Osborn
AD - Division of Psychiatry, University College London, London, United Kingdom.
Expert by Experience, United Kingdom.
Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom.
Centre for Medicines Optimisation Research and Education, University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong.
Laboratory of Data Discovery for Health (D24H), Hong Kong Science Park, Pak Shek Kok, Hong Kong.
Department of Statistical Sciences, University College London, London, United Kingdom.
Department of Public Health and Nursing, Norwegian University of Science and Technology, Trondheim, Norway.
Camden and Islington NHS Foundation Trust, London, United Kingdom.
AN - 39847591
BT - PLoS Med
C2 - PMC11778676 following competing interests: JFH has received consultancy fees from Wellcome Trust and funding grants from juli Health unrelated to the results of the current study. All other authors declare no competing interests.
DO - 10.1371/journal.pmed.1004520
DP - NLM
ET - 2025/01/23
LA - eng
M1 - 1
N1 - 1549-1676
Richards-Belle, Alvin
Orcid: 0009-0006-3232-7069
Launders, Naomi
Orcid: 0000-0003-4241-938x
Hardoon, Sarah
Richards, Al
Man, Kenneth K C
Orcid: 0000-0001-8645-1942
Davies, Neil M
Orcid: 0000-0002-2460-0508
Bramon, Elvira
Hayes, Joseph F
Orcid: 0000-0003-2286-3862
Osborn, David P J
WT_/Wellcome Trust/United Kingdom
Comparative Study
Journal Article
Observational Study
United States
PLoS Med. 2025 Jan 23;22(1):e1004520. doi: 10.1371/journal.pmed.1004520. eCollection 2025 Jan.
PY - 2025
SN - 1549-1277 (Print)
1549-1277
EP - e1004520
T2 - PLoS Med
TI - Comparative cardiometabolic safety and effectiveness of aripiprazole in people with severe mental illness: A target trial emulation
VL - 22
ER -